Dr. Oyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2102 Harrisburg Pike
Lancaster, PA 17604Phone+1 717-544-7154Fax+1 717-544-7153- Is this information wrong?
Summary
- I am a Medical Oncologist serving as the founding Medical Director of the Ann B. Barhshinger Cancer Institute Penn Medicine Lancaster General in Lancaster, Pennsylvania. I am active with ASCO and ACCC.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 1984 - 1986- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1980 - 1984
Georgetown University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1992 - 2025
PA State Medical License 1982 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
- A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
- Join now to see all
Publications & Presentations
PubMed
- Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC): study protocol for the BE-EPIC randomised controlled trial.Ravi B Parikh, Ramy Sedhom, William J Ferrell, Katherine Villarin, Kara Berwanger, Bethann Scarborough, Randall Oyer, Pallavi Kumar, Niharika Ganta, Shanthi Sivendran,...> ;BMJ Open. 2023 Mar 24
- 3 citationsToward Predicting 30-Day Readmission Among Oncology Patients: Identifying Timely and Actionable Risk Factors.Sy Hwang, Ryan Urbanowicz, Selah Lynch, Tawnya Vernon, Kellie Bresz, Carolina Giraldo, Erin Kennedy, Max Leabhart, Troy Bleacher, Michael R Ripchinski, Danielle L Mowe...> ;JCO Clinical Cancer Informatics. 2023 Feb 1
- 8 citationsAn Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials.Nadine J Barrett, Leigh Boehmer, Janelle Schrag, Al B Benson 3rd, Sybil Green, Leila Hamroun-Yazid, Alexandra Howson, Khalid Matin, Randall A Oyer, Lori Pierce, Sanfor...> ;JCO Oncology Practice. 2023 Apr 1
- Join now to see all
Press Mentions
Doctors See Both Setbacks, Advances in Breast Cancer CareOctober 4th, 2022- Rucaparib Is Effective in Maintenance Treatment for Ovarian CancerJune 8th, 2022
- Ibrutinib Extends Survival for Older Mantle Cell Lymphoma PatientsJune 8th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
Penn Medicine Lancaster General HealthLancaster, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
